{
    "clinical_study": {
        "@rank": "144671", 
        "arm_group": [
            {
                "arm_group_label": "Dexamethasone group", 
                "arm_group_type": "Active Comparator", 
                "description": "0.5% Bupivacaine with 1:200,000epinephrine + Dexamethasone 4mg(1 ml) per 20cc"
            }, 
            {
                "arm_group_label": "Saline group", 
                "arm_group_type": "Placebo Comparator", 
                "description": "0.5% Bupivacaine with 1:200,000epinephrine + Saline 1 ml per 20cc"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this research study to evaluate the effects of dexamethasone as an addition\n      to peripheral nerve block (Put the nerve to sleep with Bupivacaine a numbing medication) on\n      length of pain relief (analgesia), postoperative narcotic (opioids) requirements, pain\n      scores, and patient satisfaction after foot and ankle procedures."
        }, 
        "brief_title": "Efficacy of Popliteal Nerve Blocks With and Without Dexamethasone on the Duration of Analgesia for Foot & Ankle Surgery", 
        "completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Foot and Ankle Procedures", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  100 patients (50 per group) undergoing foot and ankle procedures\n\n          -  Willingness and ability to sign an informed consent document\n\n          -  No allergies to anesthetic or analgesic medications\n\n          -  American Society of Anesthesiologists (ASA)physical status Class I - III\n\n          -  Aged 18-90 years,either sex\n\n        Exclusion Criteria:\n\n          -  Refusal to participate in the study\n\n          -  Age<18 or> 90 years   -\n\n          -  Contraindications to regional blockage including but not limited to:\n\n          -  Patient refusal to regional blockade\n\n          -  Infection at the site of needle insertion\n\n          -  Systemic infection\n\n          -  Bleeding diathesis or coagulopathy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "90 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 29, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01975285", 
            "org_study_id": "Pro00032547"
        }, 
        "intervention": [
            {
                "arm_group_label": "Saline group", 
                "description": "0.5% Bupivacaine with 1:200,000 epinephrine + Dexamethasone 4mg per 20cc", 
                "intervention_name": "Dexamethasone", 
                "intervention_type": "Drug", 
                "other_name": "Decadron"
            }, 
            {
                "arm_group_label": "Dexamethasone group", 
                "description": "0.5% Bupivacaine with 1:200,000epinephrine + Saline 1 ml per 20cc", 
                "intervention_name": "Saline", 
                "intervention_type": "Drug", 
                "other_name": "placebo"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Epinephrine", 
                "Dexamethasone", 
                "Adjuvants, Anesthesia", 
                "Dexamethasone acetate", 
                "Dexamethasone 21-phosphate", 
                "BB 1101"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Pain management", 
            "Postoperative opioid requirements", 
            "Perioperative outcomes", 
            "Dexamethasone", 
            "Anesthetic adjuvant", 
            "Analgesic adjuvant"
        ], 
        "lastchanged_date": "November 1, 2013", 
        "location": {
            "contact": {
                "email": "Kapil.Anand@cshs.org", 
                "last_name": "Kapil Anand, MD", 
                "phone": "310-423-5841"
            }, 
            "contact_backup": {
                "email": "loanidoc@yahoo.com", 
                "last_name": "Ofelia L Elvir Lazo, MD", 
                "phone": "310-423-5841"
            }, 
            "facility": {
                "address": {
                    "city": "Los Angeles", 
                    "country": "United States", 
                    "state": "California", 
                    "zip": "90048"
                }, 
                "name": "Cedars Sinai Medical center"
            }, 
            "investigator": [
                {
                    "last_name": "Jonathan Hausman, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Antonio Hernandez Conte, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "David Thordarson, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Glenn Pfeffer, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Matt Eng, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Alyse Mousette, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Ofelia L Elvir Lazo, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Kapil Anand, MD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Prospective Randomized Double Blind Study to Evaluate the Efficacy of Popliteal Nerve Blocks With and Without Dexamethasone on the Duration of Analgesia for Foot & Ankle Surgery.", 
        "overall_contact": {
            "email": "Roya.Yumul@cshs.org", 
            "last_name": "Roya Yumul, MD, PhD", 
            "phone": "310-423-5841"
        }, 
        "overall_contact_backup": {
            "email": "loanidoc@yahoo.com", 
            "last_name": "Ofelia L Elvir Lazo, MD", 
            "phone": "310-423-5841"
        }, 
        "overall_official": {
            "affiliation": "Cedars-Sinai Medical Center", 
            "last_name": "Roya Yumul, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Postoperative will be measured at:\nPACU every 30 minutes Home:12, 24, 48, and 72 hours. Also at 1 week, one and six months after surgery.", 
            "measure": "Postoperative pain using a Verbal Rating Scale", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01975285"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Cedars-Sinai Medical Center", 
            "investigator_full_name": "Roya Yumul, M.D.,PhD.", 
            "investigator_title": "Residency program director, Department of anesthesiology", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Postoperative nausea and vomiting using a Verbal Rating Scale (0-10) at PACU, one week after surgery and one month after surgery", 
                "measure": "Nausea and vomiting will be measured with follow up", 
                "safety_issue": "No", 
                "time_frame": "1 month"
            }, 
            {
                "description": "patient satisfaction using a Verbal Rating Scale (0-10)with the overall technique", 
                "measure": "patient satisfaction", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "Opioid consumption obtained from the recorded data Perioperative use of opioid consumption inside hospital (recorded by study staff and data obtained from patient charts) Post discharge use of opioid consumption (data obtained from the follow up questionnaires approximately one week, one month and 6 months after surgery).", 
                "measure": "Opioid consumption", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "Time in days and/or hours", 
                "measure": "length of analgesia", 
                "safety_issue": "No", 
                "time_frame": "one week"
            }
        ], 
        "source": "Cedars-Sinai Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Cedars-Sinai Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}